Evaluation of serum anti‐Müllerian hormone concentrations following treatment with vitamin D in Holstein Friesian heifers

Abstract

Anti‐Müllerian hormone (AMH) levels in the blood of dairy cattle are associated with the count of antral follicles (AFC), ovarian function. Numerous studies, particularly in human medicine, have shown that vitamin D3 (Vit D3) has a positive effect on AMH levels. To our knowledge, the effects of Vit D3 on serum AMH levels in heifers have not been investigated. The goal of the current study was to evaluate the concentrations of serum AMH in dairy heifers following Vit D3 treatment. The study included 20 healthy non‐pregnant Holstein Friesian heifers. These animals came to estrus at least once. All heifers received a single intramuscular dosage of 5 million IU Vit D3 (Cholecalciferol). Blood samples were collected from the coccygeal veins of all animals before and after Vit D3 injection (days 7, 14, and 28) for the measurement of AMH and 25(OH)D concentrations. In our analysis, we observed that after exogenous Vit D3 administration, circular 25(OH)D increased constantly (up to day 28 after Vit D3 injection) in all animals. On day 28, AMH concentrations saw a 10% increase in comparison with those measured the day before the Vit D3 injection. However, a comparison of AMH concentrations measured across days did not reveal statistically significant differences between Day 0, 7, 14, and 28 levels (p = .10). Furthermore, no statistical correlation was observed between the pairs (age‐AMH) and (weight‐AMH). Considering all times, no correlation was found between 25(OH)D and blood AMH levels. These findings demonstrated that exogenous Vit D3 did not affect serum AMH in Holstein Friesian heifers.

Anti‐Müllerian hormone: A novel biomarker for detecting bovine freemartinism

“…Serum AMH levels were assessed in blood samples from G1 and G2. The measurement of AMH levels was conducted using the Elecsys AMH kit based on the electrochemiluminescence immunoassay methodology (Roche, Cobas e 601, Germany) (Anckaert et al, 2019;Deeks, 2015;Domain et al, 2022;Jacobs et al, 2019;Koca et al, 2023). Before the primary trial, the samples underwent method validation following the manufacturer's guidelines.…”